基本信息
views: 393
Career Trajectory
Bio
Dr. Kamat’s expertise is in multidisciplinary management of urologic cancers with an emphasis bladder and prostate cancer, organ sparing therapies, minimally invasive techniques, and orthotopic bladder substitution (neobladder). While he is a busy surgeon, he maintains an active research portfolio to improve the care of patients. Dr. Kamat’s efforts are directed towards identifying predictors of response to therapy - especially immunotherapy - as a first step towards personalized cancer therapeutics. A major focus of his laboratory research is to develop novel treatments for bladder cancer and identify resistance mechanisms and ways to overcome them. He serves as project PI on the MD Anderson Cancer Center GU (Bladder) SPORE.
Research Interests
Papers共 925 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Boorjian S.A.,Narayan V.M.,Konety B.R., Master V.A.,Shore N.D.,Kamat A.M.,Bivalacqua T.J., Kates M.R.,Montgomery J.S.,Crispen P.L.,Steinberg G.D., Agarwal P.K.,
European Urology (2024): S1492-S1493
Mark D. Tyson,Edward Uchio, Jong-Kil Nam,Donald L. Lamm,Trinity J. Bivalacqua,Neal D. Shore,Wassim Kassouf,Gary D. Steinberg,Peter C. Black,Ashish M. Kamat, Hiroshi Kitamura,James M. Burke,
Journal of Urologyno. 5S2 (2024)
European urology oncology (2024)
EUROPEAN UROLOGY ONCOLOGYno. 1 (2024): 44-52
Nature Medicinepp.1-1, (2024)
AMERICAN JOURNAL OF SURGICAL PATHOLOGYno. 1 (2024): E11-E23
The Lancet Oncologyno. 6 (2024): 720-730
Load More
Author Statistics
#Papers: 929
#Citation: 24864
H-Index: 82
G-Index: 139
Sociability: 8
Diversity: 3
Activity: 188
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn